Review article · 2022 · Open access

Nanocarriers for pancreatic cancer imaging, treatments, and immunotherapies

Luman Liu, Prakash Kshirsagar, Shailendra Kumar Gautam, Mansi Gulati, Emad Ibrahim Wafa, John C. Christiansen, Brianna M. White, Surya K. Mallapragada, Michael J. Wannemuehler, Sushil Kumar, Joyce C. Solheim, Surinder K. Batra and 3 more

Theranostics, 12(3), 1030–1060 · Published 1 January 2022 · DOI 10.7150/thno.64805

Open PDFView at the publisherCite this paper

In brief

“Nanocarriers for pancreatic cancer imaging, treatments, and immunotherapies” is a 2022 review article by Luman Liu and 14 co-authors, published in Theranostics. OpenAlex counts 134 citations as of 21 November 2026, which puts it in the top 1% of works published in 2022 by citations. It is open access under a CC BY licence: the full text is free to read at Theranostics.

Citations
134
Most cited in
2025 (37)
Field-weighted impact
1.79
References
374
Authors
15

Abstract

Pancreatic tumors are highly desmoplastic and immunosuppressive. Delivery and distribution of drugs within pancreatic tumors are compromised due to intrinsic physical and biochemical stresses that lead to increased interstitial fluid pressure, vascular compression, and hypoxia. Immunotherapy-based approaches, including therapeutic vaccines, immune checkpoint inhibition, CAR-T cell therapy, and adoptive T cell therapies, are challenged by an immunosuppressive tumor microenvironment. Together, extensive fibrosis and immunosuppression present major challenges to developing treatments for pancreatic cancer. In this context, nanoparticles have been extensively studied as delivery platforms and adjuvants for cancer and other disease therapies. Recent advances in nanotechnology have led to the development of multiple nanocarrier-based formulations that not only improve drug delivery but also enhance immunotherapy-based approaches for pancreatic cancer. This review discusses and critically analyzes the novel nanoscale strategies that have been used for drug delivery and immunomodulation to improve treatment efficacy, including newly emerging immunotherapy-based approaches. This review also presents important perspectives on future research directions that will guide the rational design of novel and robust nanoscale platforms to treat pancreatic tumors, particularly with respect to targeted therapies and immunotherapies. These insights will inform the next generation of clinical treatments to help patients manage this debilitating disease and enhance survival rates.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Liu, L., Kshirsagar, P., Gautam, S. K., Gulati, M., Wafa, E. I., Christiansen, J. C., White, B. M., Mallapragada, S. K., Wannemuehler, M. J., Kumar, S., Solheim, J. C., Batra, S. K., Salem, A. K., Narasimhan, B., & Jain, M. (2022). Nanocarriers for pancreatic cancer imaging, treatments, and immunotherapies. Theranostics, 12(3), 1030–1060. https://doi.org/10.7150/thno.64805

MLA 9

Liu, Luman, et al. “Nanocarriers for pancreatic cancer imaging, treatments, and immunotherapies.” Theranostics, vol. 12, no. 3, 2022, pp. 1030–1060. https://doi.org/10.7150/thno.64805.

Chicago

Liu, Luman, Prakash Kshirsagar, Shailendra Kumar Gautam, Mansi Gulati, Emad Ibrahim Wafa, John C. Christiansen, Brianna M. White, et al. 2022. “Nanocarriers for pancreatic cancer imaging, treatments, and immunotherapies.” Theranostics 12 (3): 1030–1060. https://doi.org/10.7150/thno.64805.

Harvard

Liu, L. et al. (2022) ‘Nanocarriers for pancreatic cancer imaging, treatments, and immunotherapies’, Theranostics, 12(3), pp. 1030–1060. doi:10.7150/thno.64805.

IEEE

L. Liu et al., “Nanocarriers for pancreatic cancer imaging, treatments, and immunotherapies,” Theranostics, vol. 12, no. 3, pp. 1030–1060, 2022, doi: 10.7150/thno.64805.

BibTeX

@article{liu2022nanocarriers,
  title     = {{Nanocarriers for pancreatic cancer imaging, treatments, and immunotherapies}},
  author    = {Liu, Luman and Kshirsagar, Prakash and Gautam, Shailendra Kumar and Gulati, Mansi and Wafa, Emad Ibrahim and Christiansen, John C. and White, Brianna M. and Mallapragada, Surya K. and Wannemuehler, Michael J. and Kumar, Sushil and Solheim, Joyce C. and Batra, Surinder K. and Salem, Aliasger K. and Narasimhan, Balaji and Jain, Maneesh},
  journal   = {Theranostics},
  year      = {2022},
  volume    = {12},
  number    = {3},
  pages     = {1030--1060},
  doi       = {10.7150/thno.64805},
  url       = {https://doi.org/10.7150/thno.64805}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
20221717
20232727
20243434
20253737
20261919

Its field-weighted citation impact is 1.79: it has been cited 1.79 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery

  • pancreatic cancer
  • nanocarriers
  • drug delivery
  • tumor immunosuppression
  • tumor microenvironment
  • desmoplasia
  • tumor hypoxia
  • interstitial fluid pressure

Work with this paper

Most-cited papers in Materials Science

All highly cited Materials Science papers

Questions about this paper

How do I cite this paper in APA style?

Liu, L., Kshirsagar, P., Gautam, S. K., Gulati, M., Wafa, E. I., Christiansen, J. C., White, B. M., Mallapragada, S. K., Wannemuehler, M. J., Kumar, S., Solheim, J. C., Batra, S. K., Salem, A. K., Narasimhan, B., & Jain, M. (2022). Nanocarriers for pancreatic cancer imaging, treatments, and immunotherapies. Theranostics, 12(3), 1030–1060. https://doi.org/10.7150/thno.64805

How many times has this paper been cited?

134 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Theranostics: sign in and open the PDF from this page.

Who wrote this paper?

Luman Liu, Prakash Kshirsagar, Shailendra Kumar Gautam, Mansi Gulati, Emad Ibrahim Wafa, John C. Christiansen, Brianna M. White, Surya K. Mallapragada, Michael J. Wannemuehler, Sushil Kumar, Joyce C. Solheim, Surinder K. Batra and 3 more.

What is the DOI of this paper?

10.7150/thno.64805, permanently at https://doi.org/10.7150/thno.64805. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.